News
Nov-2021
Nov-2021 Tranquil Clinical Research successfully completed a Phase II double blind, placebo controlled COVID trial as the full service CRO conducting all clinical trial operations including Protocol development, FDA submissions/approvals, pharmacovigilance, clinical project management, clinical operations and with the highest...
continue reading
Feb 2022 – 35% minority enrollment
Tranquil Clinical Research was the only clinical research unit selected to enroll 200 subjects on a device collection trial and successfully enrolled all 200 subjects (achieving 35% minorities) within 10 business days.
continue reading
We had our annual company conference in magical Disney World.
Tranquil Clinical Research works hard, trains hard and plays hard. We had our annual company conference in magical Disney World.
continue reading
Tranquil Clinical Research successfully completed a Phase II clinical trial in COVID patients.
Tranquil Clinical Research successfully completed a Phase II clinical trial in COVID patients as the CRO conducting all clinical trial operations including: Protocol development, FDA submissions/approvals, pharmacovigilance, clinical project management, clinical operations and with the highest level of quality deliverables...
continue reading
Device Trial Rapid Enrollment
Tranquil Clinical Research successfully recruited and enrolled a difficult interventional device trial within two months; where the sponsor's other sites were unable to enroll in 18 months; becoming the highest enrolling clinical research unit and with 100% quality dat
continue reading
Study of COVID treatment Quellor has first patient at Louisville hospital
Tranquil is proud to announce the success of our strategic research site partner, the cardiology research team at Jewish Hospital in Louisville, KY! Dr. Naresh Solankhi & his team successfully treated the the first US patient to participate in a...
continue reading